Ultrasound-Guided Corticosteroid and Bupivacaine for Facial Nerve Function and Thickness in Bell's Palsy

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

October 1, 2024

Study Completion Date

February 1, 2025

Conditions
Bell's Palsy
Interventions
DRUG

Triamcinolone and Bupivacaine Injection

A single injection consisting of 1 cc of 0.25% bupivacaine mixed with 2 cc (20 mg) of triamcinolone (40 mg/mL) is administered under ultrasound guidance. The injection targets the extratemporal portion of the facial nerve approximately 1.5-2 cm distal to the stylomastoid foramen in an inferior and anterior direction. The intervention is designed to reduce inflammation and pain, potentially accelerating facial nerve recovery in acute Bell's palsy.

Trial Locations (1)

Unknown

Tishreen University Hospital, Latakia

All Listed Sponsors
lead

Tishreen University Hospital

OTHER

NCT06955455 - Ultrasound-Guided Corticosteroid and Bupivacaine for Facial Nerve Function and Thickness in Bell's Palsy | Biotech Hunter | Biotech Hunter